Role of KRAS let-7 LCS6 SNP in metastatic colorectal cancer patients

Ann Oncol. 2011 Jan;22(1):234-235. doi: 10.1093/annonc/mdq472. Epub 2010 Oct 6.

Authors

A Ruzzo¹, E Canestrari², N Galluccio², D Santini³, B Vincenzi³, G Tonini³, M Magnani², F Graziano⁴

Affiliations

¹ Department of Biomolecular Sciences, University of Urbino, Urbino. Electronic address: annamaria.ruzzo@uniurb.it.
² Department of Biomolecular Sciences, University of Urbino, Urbino.
³ Medical Oncology Unit, University Campus Bio-Medico, Rome.
⁴ Department of Onco-Hematology, Division of Oncology, Azienda Ospedale San Salvatore, Pesaro, Italy.

PMID: 20926546
DOI: 10.1093/annonc/mdq472

No abstract available

Publication types

Comment
Letter

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antibodies, Monoclonal, Humanized
Antineoplastic Agents / therapeutic use
Cetuximab
Colorectal Neoplasms / drug therapy
Colorectal Neoplasms / genetics*
Genes, ras*
Humans
MicroRNAs / genetics*
Polymorphism, Single Nucleotide

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
MicroRNAs
mirnlet7 microRNA, human
Cetuximab